Take 2 capsules of the Metabolism Optimization Formula daily, ideally within 1 hour of waking and before food. Avoid taking it after 4pm.

• Initial: Set Baseline Fatigue Levels, Start Body Composition & Weight, and Baseline BMR.
• Follow-up: Conduct Safety & Side Effect Check-in, Neuro-QOL Fatigue Assessment, Body Composition Measurement, and BMR Estimation.

The "90 Day Metabolism Optimization Protocol" is an exploratory single-arm observational trial designed to investigate the potential benefits of a metabolism support formula over a 90-day period. Participants will act as their own controls, allowing researchers to observe changes in personal metrics over time without the influence of an external control group. This study falls under Efforia's "Signal Phase" studies, which aim to provide preliminary evidence of efficacy and safety. Participants will engage in a daily routine of consuming two capsules of the metabolism support formula and will track changes in weight, energy levels, and appetite signals through structured check-ins. The trial will collect baseline and follow-up data to offer a clear before-and-after view of individual results, thereby providing insights that are tailored to each participant.

The study's methodology emphasizes a structured, evidence-based approach to understanding metabolism's role in weight management. Participants will be guided by Elwin Robinson through the process, which includes initial measurements such as baseline fatigue levels, body composition, and basal metabolic rate (BMR). Throughout the study, participants will maintain daily logs of their weight, body temperature, and energy levels, facilitated by tools such as a cloth tape measure and an accurate thermometer. The study aims to explore whether the metabolism support formula can enhance the body's ability to utilize calories effectively, potentially supporting weight management without altering calorie intake. This approach not only provides participants with personalized insights but also helps build a foundation of safety data that is currently limited.

Participation in this study is vital as it contributes to a broader understanding of metabolism optimization and its potential impacts. The data collected will be handled securely and with confidentiality, following privacy standards. Participants are encouraged to remain consistent in their engagement with the protocol to maximize the utility of their results. Should positive signals emerge from this trial, indicating that the intervention is effective, the findings will inform the design of more robust studies in the future. This exploratory phase is crucial for paving the way for extensive research and development in the field of metabolism support and weight optimization. For more detailed information, participants and interested parties are directed to consult the "Minimal Risk Umbrella protocol."

The statistical plan for the "90 Day Metabolism Optimization Protocol" is designed to align with the standards and guidelines set forth by the Minimal Risk Umbrella protocol. This ensures that our approach to data collection, analysis, and interpretation is both rigorous and consistent with established minimal risk research methodologies.

For those reviewers interested in a detailed assessment of the statistical plan, we recommend consulting the overarching Minimal Risk Umbrella protocol. This document provides comprehensive insight into the statistical methodologies and considerations applied across studies within this framework, ensuring consistency and adherence to best practices.

In our study, we will utilize the measures specified, such as the Neuro-QOL Item Bank v1.0 – Fatigue – Short Form and the Body Composition Measurement Form, to gather data on key outcomes like fatigue levels and waist circumference. These measures will be analyzed in accordance with the statistical guidelines outlined in the umbrella protocol, ensuring accurate and reliable results.

We trust that by referring to the umbrella protocol, reviewers will gain a thorough understanding of the statistical integrity and methodological soundness underpinning our study. If there are any specific questions or if additional documentation is needed, we are more than willing to provide further clarification to facilitate the review process.

The single-arm observational trial design, while offering valuable insights into the impact of the Metabolism Support Formula on metabolic function, comes with inherent limitations, primarily the absence of a control group. This lack of a comparator can lead to biases in interpreting the effects of the intervention, as changes in metabolic function, fatigue, and body composition could be influenced by placebo effects or external factors rather than the formula itself. To address this, we have incorporated an expectations questionnaire to assess participant bias and expectations. This tool allows us to quantify how much participant perceptions may affect the outcomes, providing a clearer picture of the formula's true effects. Despite these limitations, this approach aligns with the Efforia and Minimal Risk Umbrella Protocol's mission to democratize clinical research by enabling exploratory studies that might otherwise be overlooked.

The study's design includes careful consideration of sample size and statistical methods, such as potential stratification by participant demographics, which are critical in mitigating biases typical of single-arm trials. These strategies ensure a more nuanced analysis of the data, accounting for variability among participants in terms of age, gender, and baseline metabolic health. By doing so, we aim to enhance the validity of our findings, despite the trial's observational nature. Furthermore, the study's primary objective is to serve as a signal detection initiative; positive results will prompt more rigorous controlled trials to further substantiate and replicate these preliminary findings. This phased approach not only enhances the robustness of our research but also aligns with our goal of empowering participants with actionable insights into their metabolic health.

Moreover, this study's alignment with the Minimal Risk Citizen Science Umbrella Protocol underscores our commitment to accessible and inclusive research. By targeting adults over the age of 18 interested in improving their metabolic function, we open the door to a broad audience who might benefit from personalized health insights and wellness optimization. The trial's low-risk nature and focus on democratizing research ensure that we can address questions often neglected in traditional clinical settings, providing a platform for both participants and researchers to explore innovative wellness strategies. Participants are empowered to make informed health choices, contributing to a broader understanding of metabolic enhancement and weight management, while the ongoing documentation of risks and safety measures ensures participant well-being throughout the study.